BUZZ-Hinge Health climbs after forecasting FY26 revenue above estimates

Reuters02-11
BUZZ-<a href="https://laohu8.com/S/HNGE">Hinge Health</a> climbs after forecasting FY26 revenue above estimates 

** Shares of AI health platform Hinge Health HNGE.N up 13.8% at $37.60 premarket after co forecasts FY26 revenue above estimates

** Co sees FY26 rev between $732 mln-$742 mln, above analyst est. of $717.41 mln, per data compiled by LSEG

** CEO Daniel Perez says strong year‑end sales momentum and record customer wins boosted growth and widened margins

** Co posts Q4 rev of $170.7 mln, beating expectation of $156.6 mln; Q4 adj EPS of 49 cents, above estimates of 39 cents

** 16 out of 17 analysts rate stock "buy" or higher, one "hold"; median PT at $59.50 - data compiled by LSEG

** Hinge Health debuted in May 2025 with IPO price of $32; stock down 28.8% YTD

(Reporting by Tharuniyaa Lakshmi in Bengaluru)

((tharuniyaa@thomsonreutrs.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment